Serveur d'exploration SRAS - Exploration (Accueil)

Index « Keywords » - entrée « Lopinavir »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Loperamide (pharmacology) < Lopinavir < Lopinavir (administration & dosage)  Facettes :

List of bibliographic references indexed by Lopinavir

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
003071 (2008) Veena Nukoolkarn [Thaïlande] ; Vannajan Sanghiran Lee ; Maturos Malaisree ; Ornjira Aruksakulwong ; Supot HannongbuaMolecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors.
003637 (2007) Dessmon Y H. Tai [Singapour]Pharmacologic treatment of SARS: current knowledge and recommendations.
003C26 (2006) Yazdan Yazdanpanah ; Benoît Guéry[Antiretroviral drugs in severe acute respiratory syndrome].
003C98 (2006) Rolf Hilgenfeld [Allemagne] ; Ksenia PumporSometimes intermediates. Do the job!
005478 (2004) David S C. Hui [Hong Kong] ; Gary W K. WongAdvancements in the battle against severe acute respiratory syndrome.
005583 (2004) Xiao Ping Chen ; Yunzhen Cao [République populaire de Chine, États-Unis]Consideration of Highly Active Antiretroviral Therapy in the Prevention and Treatment of Severe Acute Respiratory Syndrome
005A70 (2004) Tai-Nin Chau [Hong Kong] ; Kam-Cheong Lee [Hong Kong] ; HUNG YAO [Hong Kong] ; Tak-Yin Tsang [Hong Kong] ; Tat-Chong Chow [Hong Kong] ; Yiu-Cheong Yeung [Hong Kong] ; Kin-Wing Choi [Hong Kong] ; Yuk-Keung Tso [Hong Kong] ; Terence Lau [Hong Kong] ; Sik-To Lai [Hong Kong] ; Ching-Lung Lai [Hong Kong]SARS-Associated viral hepatitis caused by a novel coronavirus: Report of three cases
005A98 (2004) XUE WU ZHANG [Hong Kong] ; YEE LENG YAP [Hong Kong]Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs
005B20 (2004) F. Chen [Hong Kong] ; K. H. Chan [Hong Kong] ; Y. Jiang [Hong Kong] ; R. Y. T. Kao [Hong Kong] ; H. T. Lu [Hong Kong] ; K. W. Fan [Hong Kong] ; V. C. C. Cheng [Hong Kong] ; W. H. W. Tsui [Hong Kong] ; I. F. N. Hung [Hong Kong] ; T. S. W. Lee [Hong Kong] ; Y. Guan [Hong Kong] ; J. S. M. Peiris [Hong Kong] ; K. Y. Yuen [Hong Kong]In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
005B61 (2004) XIAO PING CHEN [République populaire de Chine] ; YUNZHEN CAO [République populaire de Chine, États-Unis]Consideration of highly active antiretroviral therapy in the prevention and treatment of severe acute respiratory syndrome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Lopinavir" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Lopinavir" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Lopinavir
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021